COM:INTELLIATX
Intellia Therapeutics
- Stock
Last Close
13.80
22/11 21:00
Market Cap
2.23B
Beta: -
Volume Today
2.41M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
net income | -12.40M - | -31.63M 155.17% | -67.54M 113.51% | -85.34M 26.35% | -99.53M 16.63% | -134.23M 34.86% | -267.89M 99.58% | -474.19M 77.01% | -481.19M 1.48% | |
depreciation and amortization | 328K - | 1.10M 236.59% | 2.99M 171.20% | 4.46M 49.10% | 5.59M 25.16% | 6.31M 12.96% | 6.89M 9.19% | 7.57M 9.88% | 8.98M 18.54% | |
deferred income tax | -1.01M - | -6.70M 562.25% | 8.93M - | -10.19M - | ||||||
stock based compensation | 1.31M - | 6.71M 413.38% | 15.32M 128.18% | 17.05M 11.25% | 15.09M 11.47% | 19.90M 31.89% | 47.01M 136.19% | 91.40M 94.43% | 134.05M 46.66% | |
change in working capital | 10.00M - | 59.91M 499.05% | -16.21M 127.07% | 3.18M 119.59% | -20.66M 750.33% | 57.53M 378.46% | -22.90M 139.81% | -53.87M 135.21% | -52.45M 2.64% | |
accounts receivables | -5.45M - | -4.02M 26.35% | 2.92M 172.79% | 2.93M 0.10% | 2.49M 14.93% | 99K 96.02% | -1.74M 1,854.55% | -32.69M 1,781.87% | ||
inventory | -4.39M - | 1.28M 129.09% | 3.96M 209.62% | 1.65M 58.20% | 4.86M 193.89% | 7.82M 60.93% | -19.51M - | |||
accounts payables | 335K - | 1.78M 432.54% | -488K 127.35% | 232K 147.54% | 1.88M 710.34% | 5.06M 169.15% | 529K 89.55% | -4.58M 966.54% | 2.52M 155.02% | |
other working capital | 9.67M - | 67.97M 603.24% | -12.99M 119.11% | -3.94M 69.70% | -27.12M 589.08% | 45.12M 266.36% | -31.36M 169.49% | -47.55M 51.66% | -2.78M 94.16% | |
other non cash items | 9K - | 6.71M 74,511.11% | 166K 97.53% | -601K 462.05% | -3.72M 519.63% | 573K 115.39% | 2.94M 412.57% | 95.80M 3,161.83% | 6.72M 92.98% | |
net cash provided by operating activities | -1.76M - | 36.11M 2,148.16% | -65.28M 280.77% | -61.26M 6.16% | -103.24M 68.54% | -49.91M 51.65% | -225.03M 350.85% | -333.29M 48.11% | -394.09M 18.24% | |
investments in property plant and equipment | -2.55M - | -6.17M 141.39% | -10.09M 63.68% | -6.36M 36.99% | -6.79M 6.86% | -3.58M 47.23% | -12.76M 255.82% | -58.39M 357.75% | -13.98M 76.05% | |
acquisitions net | -31.97M - | 210.90M 759.69% | -3M 101.42% | -44.68M 1,389.40% | ||||||
purchases of investments | -254.56M - | -297.03M 16.69% | -473.70M 59.48% | -1.02B 115.46% | -429.03M 57.96% | -904.46M 110.82% | ||||
sales maturities of investments | 329M - | 262.80M 20.12% | 485.60M 84.78% | 647.58M 33.36% | 887.10M 36.99% | |||||
other investing activites | 131K - | 31.97M 24,304.58% | -210.90M 759.69% | 44.83M - | ||||||
net cash used for investing activites | -2.55M - | -6.17M 141.39% | -10.09M 63.68% | -260.78M 2,484.30% | 25.18M 109.65% | -214.49M 951.95% | -550.78M 156.79% | 160.31M 129.11% | -31.35M 119.55% | |
debt repayment | ||||||||||
common stock issued | 170.51M - | 141M 17.31% | 28.97M 79.45% | 72.26M 149.41% | 358.65M 396.36% | 693.57M 93.38% | 565.79M 18.42% | 119.80M 78.83% | ||
common stock repurchased | -2.67M - | -100K 96.26% | ||||||||
dividends paid | ||||||||||
other financing activites | 72.96M - | -3.10M 104.25% | 1.98M 163.84% | 11.25M 467.69% | 4.18M 62.85% | 13.13M 214.29% | 43.12M 228.37% | 17.17M 60.19% | 10.53M 38.67% | |
net cash used provided by financing activities | 70.29M - | 167.30M 138.03% | 142.98M 14.54% | 40.22M 71.87% | 76.43M 90.05% | 371.78M 386.41% | 736.69M 98.15% | 582.96M 20.87% | 130.32M 77.64% | |
effect of forex changes on cash | ||||||||||
net change in cash | 65.97M - | 197.25M 198.99% | 67.61M 65.72% | -281.82M 516.81% | -1.63M 99.42% | 107.38M 6,687.73% | -39.12M 136.43% | 409.98M 1,148.00% | -295.11M 171.98% | |
cash at beginning of period | 9.85M - | 75.82M 670.10% | 273.06M 260.17% | 340.68M 24.76% | 58.86M 82.72% | 57.23M 2.77% | 164.61M 187.64% | 125.49M 23.77% | 535.46M 326.71% | |
cash at end of period | 75.82M - | 273.06M 260.17% | 340.68M 24.76% | 58.86M 82.72% | 57.23M 2.77% | 164.61M 187.64% | 125.49M 23.77% | 535.46M 326.71% | 240.35M 55.11% | |
operating cash flow | -1.76M - | 36.11M 2,148.16% | -65.28M 280.77% | -61.26M 6.16% | -103.24M 68.54% | -49.91M 51.65% | -225.03M 350.85% | -333.29M 48.11% | -394.09M 18.24% | |
capital expenditure | -2.55M - | -6.17M 141.39% | -10.09M 63.68% | -6.36M 36.99% | -6.79M 6.86% | -3.58M 47.23% | -12.76M 255.82% | -58.39M 357.75% | -13.98M 76.05% | |
free cash flow | -4.32M - | 29.94M 793.63% | -75.37M 351.69% | -67.61M 10.29% | -110.03M 62.74% | -53.50M 51.38% | -237.79M 344.48% | -391.68M 64.72% | -408.07M 4.19% |
All numbers in USD (except ratios and percentages)